|
Volumn 287, Issue 13, 2002, Pages 1640-
|
Pediatric use of mevacor
a
a
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APOLIPOPROTEIN B;
CHOLESTEROL;
HYPOCHOLESTEROLEMIC AGENT;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
PLACEBO;
ANTINEOPLASTIC AGENT;
IBRITUMOMAB TIUXETAN;
INDIUM;
MONOCLONAL ANTIBODY;
RADIOPHARMACEUTICAL AGENT;
YTTRIUM;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
DIET THERAPY;
DRUG APPROVAL;
DRUG INDICATION;
FAMILIAL HYPERCHOLESTEROLEMIA;
FAMILY HISTORY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
PRIORITY JOURNAL;
RISK FACTOR;
SHORT SURVEY;
SIDE EFFECT;
TREATMENT OUTCOME;
ADOLESCENT;
ARTICLE;
HYPERLIPOPROTEINEMIA TYPE 2;
NONHODGKIN LYMPHOMA;
RADIOIMMUNOTHERAPY;
UNITED STATES;
ADOLESCENT;
ANTIBODIES, MONOCLONAL;
ANTICHOLESTEREMIC AGENTS;
ANTINEOPLASTIC AGENTS;
HUMANS;
HYPERLIPOPROTEINEMIA TYPE II;
INDIUM RADIOISOTOPES;
LOVASTATIN;
LYMPHOMA, NON-HODGKIN;
RADIOIMMUNOTHERAPY;
RADIOPHARMACEUTICALS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
YTTRIUM RADIOISOTOPES;
|
EID: 0037012587
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.287.13.1640-a Document Type: Short Survey |
Times cited : (7)
|
References (0)
|